2.235
price down icon11.31%   -0.285
after-market After Hours: 2.24 0.005 +0.22%
loading

Prime Medicine Inc Stock (PRME) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
0.591
- - - -
Operating Expenses
28.09%
48.93
68.04 51.46 45.26 40.03
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
48.93
- - - -
Operating Income/Loss
28.96%
-48.34
-68.04 -51.46 -45.26 -40.03
Nonoperating Income/Loss
13.08%
2.714
2.40 0.643 2.903 0.434
Income/Loss From Continuing Operations Before Tax
100.90%
0.591
-65.64 -50.82 -42.38 -39.40
Income Tax Expense/Benefit, Deferred
0.134
- -0.108 0.031 -0.202
Income Tax Expense/Benefit
0.134
- -0.108 0.031 -0.202
Income/Loss From Continuing Operations After Tax
30.29%
-45.76
-65.64 -50.71 -42.38 -39.40
Net Income/Loss
30.29%
-45.76
-65.64 -50.71 -42.38 -39.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
20,816%
104.47
0.4995 91.85 90.47 89.06
Diluted Average Shares
20,816%
104.47
0.4995 91.85 90.47 89.06
Basic Earnings Per Share
38.89%
-0.44
-0.72 -0.55 -0.47 -0.44
Diluted Earnings Per Share
38.89%
-0.44
-0.72 -0.55 -0.47 -0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Cap:     |  Volume (24h):